Cardio Diagnostics gets CMS gapfill payment rates for cardiovascular tests

Cardio Diagnostics (CDIO) announced that the Centers for Medicare and Medicaid Services, through the MolDX program, has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD and $684.76 for PrecisionCHD. These preliminary rates, part of the 2025 gapfill pricing process, are expected to be finalized later this year and effective for claims on or after January 1, 2025. The company stated this is a critical step toward expanding access to its advanced cardiovascular testing for Medicare beneficiaries.